April #34 : Pipeline Dreams

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Faith, Hope and Monica

Vintage Gallo

Silence=Deaf

At the End of the Pier

Mourning Becomes Montero

Baby Love

Chris Crossed

Faith Healing

Do Tell

What This Means: Have Mass, Will Travel

Money: Fine Whines

Less is More

POZ Picks: The Complete Bedside Companion

POZ Verse: Fever

At the End of the Pier

Coming soon to a theater near you

Daytime Trauma

Even Good Boys Do Fail

Relishing Our Time

Killing Me Softly

S.O.S.

Obits

Say What

Shalala Infections

The Fraud Squad

Reefer Badness

Brain Gain

Pipeline Dreams

Virtual Activism

Fruit Loops

What's Cookin'?

United Way

La Bomba

War-Torn Nation



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

April 1998

Pipeline Dreams

124 new meds on the move

In 1987, AZT was the only med to treat HIV. Last year saw protease inhibitors for tots and a dandy new two-in-one drug. This year the store may hold much more. A survey by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the nation's leading drug and biotech research firms, revealed 124 new HIV medicines and vaccines in clinical trials or under FDA review. These meds-in-progress will add to the roster of 50 drugs already approved to treat AIDS and its associated illnesses. Among them are 40 antivirals (including protease inhibitors), 11 anti-infectives to fight opportunistic infections and five gene therapies designed to scramble cell DNA to increase resistance to the virus. When will they hatch? "We've seen an incredible improvement in FDA-review time," said PhRMA's Heather Kolasch. "A lot of the AIDS therapies are on the fast track, and approval time has been decreased to about 18 months for a new drug."




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.